MME and Alzheimer disease: Increasing the NEP level in AD-transgenic mouse models, either by direct injection of NEP into the brain [12] or by transgenic or viral-mediated overexpression of NEP in the brain or peripheral tissues, reduced the Aβ load and improved memory impairment [13–17].